Study analysis · Radiology · 2024
Your heart scan shows ZERO calcium—here’s why that could save you from a heart attack (and unnecessary surgery).
If your heart scan shows no calcium, you’re 92% less likely to have a heart attack or stroke in the next few years—even if you have chest pain.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study found that people with more calcium in their heart arteries were more likely to have heart problems later, but it didn't make the calcium happen—it just noticed who had it. So we can say calcium is a warning sign, not the cause.
What’s the bottom line?
Doctors used a special heart scan to check for calcium buildup in arteries of people with chest pain who were being considered for invasive tests.
How strong is this study?
This was a really good study because it followed lots of people from many countries, used the same tests on everyone, and checked for other things that could affect heart health. That makes us trust the results more than if it were just a few people or done in one clinic.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
81 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1749)+20/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 573 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design cannot establish causation — the findings describe an association, not a cause. Although this is a randomized trial, the randomization was applied to the choice of diagnostic test (CT vs ICA), not to CAC score levels. CAC score is an observed baseline characteristic, not a randomized intervention. Therefore, the association between CAC score and MACE is observational within the randomized trial and cannot establish causation.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study appears independently conducted with no evidence of industry control over design, analysis, or publication.
Funders
Independent Analysis Safeguards
- Prespecified subgroup analysis within a multicenter randomized trial
- Ethical review by multiple national and local ethics committees
- Statistical analysis plan pre-registered (DISCHARGE SAP)
- Data analyzed by experienced radiologists using standardized Agatston method
The study is part of the DISCHARGE trial, which received funding from multiple public and non-industry sources across 16 European countries. No industry funding or author affiliations with commercial entities are disclosed. The methodology is transparent, with pre-registered analysis plans and standardized imaging protocols, reducing risk of bias.
Key takeaways
- 01
People with no calcium (CAC score 0) had only a 0.5% chance of having a heart attack, stroke, or dying from heart disease in 3.5 years.
- 02
Those with lots of calcium (score ≥400) had a 6.8% chance.
- 03
The more calcium, the higher the risk.
- 04
Yes — if your scan shows no calcium, your risk of a major heart event is very low, even if you have chest pain.
- 05
This could help avoid unnecessary invasive procedures.
Surprising findings
- A CAC score of 0 ruled out obstructive CAD in 96% of patients (only 4.1% had blockages), even though they were all referred for invasive angiography—meaning most were likely over-tested.Doctors typically assume chest pain + intermediate risk = high chance of blockage. But this shows most of these patients had no significant disease at all.
- The risk of major events in the zero-CAC group (0.5%) was lower than the baseline risk in many asymptomatic populations studied in prior trials.Even in high-risk patients referred for invasive tests, having no calcium meant they were safer than many healthy people without symptoms.
Practical takeaways
If you have stable chest pain and are being referred for an invasive heart test, ask your doctor: 'Can I get a coronary calcium scan first?' If it’s zero, you may avoid unnecessary surgery.
This applies only to patients with stable chest pain and intermediate risk—not those with acute symptoms like crushing chest pain or shortness of breath at rest.
high confidenceWhy this study matters
Zero Calcium = Near-Zero Risk
Among 1,749 patients with stable chest pain referred for invasive heart tests, those with a coronary artery calcium (CAC) score of 0 had only a 0.5% chance of a major heart event (heart attack, stroke, or cardiac death) over 3.5 years—compared to 6.8% for those with a score of 400 or higher.
This means you could avoid invasive procedures like stents or bypass surgery if your scan is clean—even if you’re experiencing chest pain, which usually triggers immediate concern.
Calcium Score Predicts Blockages Better Than Symptoms
A CAC score of 0 was linked to just 4.1% prevalence of obstructive coronary artery disease, while a score ≥400 meant 76.1% had dangerous blockages. Chest pain alone is a poor predictor—calcium is the real signal.
People think chest pain = blocked artery. This study proves that’s often wrong—your calcium score tells the real story, not your symptoms.
Women Benefit Just as Much as Men
Despite historical bias in heart research, this study found no significant difference in MACE risk between men and women with the same CAC scores—proving calcium scoring works equally well for both sexes.
Women’s heart disease is often missed or misdiagnosed. This gives them a reliable, gender-neutral tool to assess real risk.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Doctors used a special heart scan to check for calcium buildup in arteries of people with chest pain who were being considered for invasive tests.
Research results
People with no calcium (CAC score 0) had only a 0.5% chance of having a heart attack, stroke, or dying from heart disease in 3.5 years. Those with lots of calcium (score ≥400) had a 6.8% chance. The more calcium, the higher the risk.
What this means - more context
Yes — if your scan shows no calcium, your risk of a major heart event is very low, even if you have chest pain. This could help avoid unnecessary invasive procedures.
To assess whether coronary artery calcium (CAC) scoring predicts major adverse cardiovascular events (MACE) in patients with stable chest pain referred for invasive coronary angiography.
In 1749 patients with stable chest pain referred for invasive angiography, a CAC score of 0 was associated with a 92% lower risk of MACE over 3.5 years compared to those with a score ≥400 (0.5% vs 6.8% event rate). Higher CAC scores correlated with increased obstructive CAD, revascularization, and MACE, with no significant sex-based differences in risk prediction.
Methods Used
Prespecified subgroup analysis of the DISCHARGE trial, a multicenter randomized controlled trial. Participants underwent noncontrast CT for CAC scoring (Agatston method), categorized into groups: 0, 1–399, and ≥400. MACE (cardiovascular death, myocardial infarction, stroke) was tracked over median 3.5-year follow-up using Cox proportional hazards regression adjusted for age, sex, and cardiovascular risk factors.
Main Finding
A CAC score of 0 was associated with a 92% lower risk of MACE (HR 0.08 [95% CI: 0.02–0.30]) compared to a score ≥400 (6.8% event rate), while scores of 1–399 showed intermediate risk (1.9%, HR 0.27 [95% CI: 0.13–0.59]). CAC score strongly predicted obstructive CAD (4.1% vs 76.1%) and revascularization rates (1.7% vs 46.2%).
Confidence Level
High. Prospective, multicenter, randomized trial with prespecified analysis, adjusted Cox regression, large sample (n=1749), consistent effect sizes, and reporting of confidence intervals and p-values.
Study Flags
Red Flags
- •Study is a subgroup analysis of a larger RCT, not the primary outcome
- •Follow-up is limited to 3.5 years — long-term durability unknown
- •CAC scoring was performed on CT scans from 13 different scanner models, potential for variability despite standardization
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
A CAC score of 0 ruled out obstructive CAD in 96% of patients (only 4.1% had blockages), even though they were all referred for invasive angiography—meaning most were likely over-tested.
Doctors typically assume chest pain + intermediate risk = high chance of blockage. But this shows most of these patients had no significant disease at all.
Practical Takeaways
If you have stable chest pain and are being referred for an invasive heart test, ask your doctor: 'Can I get a coronary calcium scan first?' If it’s zero, you may avoid unnecessary surgery.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 573 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study found that people with more calcium in their heart arteries were more likely to have heart problems later, but it didn't make the calcium happen—it just noticed who had it. So we can say calcium is a warning sign, not the cause.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Randomized controlled trial design with high external validity
- Large, multicenter, multinational sample (1749 participants)
- Prespecified subgroup analysis with pre-registered statistical plan
Weaknesses
- CAC score was not randomized; it is an observational baseline variable
- Blinding was unknown, potentially introducing detection bias in outcome assessment
- Follow-up duration (median 3.5 years) is insufficient to assess long-term prognostic value
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Doctors used a special heart scan to check for calcium buildup in arteries of people with chest pain who were being considered for invasive tests.
Research results
People with no calcium (CAC score 0) had only a 0.5% chance of having a heart attack, stroke, or dying from heart disease in 3.5 years. Those with lots of calcium (score ≥400) had a 6.8% chance. The more calcium, the higher the risk.
What this means - more context
Yes — if your scan shows no calcium, your risk of a major heart event is very low, even if you have chest pain. This could help avoid unnecessary invasive procedures.
To assess whether coronary artery calcium (CAC) scoring predicts major adverse cardiovascular events (MACE) in patients with stable chest pain referred for invasive coronary angiography.
In 1749 patients with stable chest pain referred for invasive angiography, a CAC score of 0 was associated with a 92% lower risk of MACE over 3.5 years compared to those with a score ≥400 (0.5% vs 6.8% event rate). Higher CAC scores correlated with increased obstructive CAD, revascularization, and MACE, with no significant sex-based differences in risk prediction.
Methods Used
Prespecified subgroup analysis of the DISCHARGE trial, a multicenter randomized controlled trial. Participants underwent noncontrast CT for CAC scoring (Agatston method), categorized into groups: 0, 1–399, and ≥400. MACE (cardiovascular death, myocardial infarction, stroke) was tracked over median 3.5-year follow-up using Cox proportional hazards regression adjusted for age, sex, and cardiovascular risk factors.
Main Finding
A CAC score of 0 was associated with a 92% lower risk of MACE (HR 0.08 [95% CI: 0.02–0.30]) compared to a score ≥400 (6.8% event rate), while scores of 1–399 showed intermediate risk (1.9%, HR 0.27 [95% CI: 0.13–0.59]). CAC score strongly predicted obstructive CAD (4.1% vs 76.1%) and revascularization rates (1.7% vs 46.2%).
Confidence Level
High. Prospective, multicenter, randomized trial with prespecified analysis, adjusted Cox regression, large sample (n=1749), consistent effect sizes, and reporting of confidence intervals and p-values.
Study Flags
Red Flags
- •Study is a subgroup analysis of a larger RCT, not the primary outcome
- •Follow-up is limited to 3.5 years — long-term durability unknown
- •CAC scoring was performed on CT scans from 13 different scanner models, potential for variability despite standardization
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
A CAC score of 0 ruled out obstructive CAD in 96% of patients (only 4.1% had blockages), even though they were all referred for invasive angiography—meaning most were likely over-tested.
Doctors typically assume chest pain + intermediate risk = high chance of blockage. But this shows most of these patients had no significant disease at all.
Practical Takeaways
If you have stable chest pain and are being referred for an invasive heart test, ask your doctor: 'Can I get a coronary calcium scan first?' If it’s zero, you may avoid unnecessary surgery.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 573 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study found that people with more calcium in their heart arteries were more likely to have heart problems later, but it didn't make the calcium happen—it just noticed who had it. So we can say calcium is a warning sign, not the cause.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Randomized controlled trial design with high external validity
- Large, multicenter, multinational sample (1749 participants)
- Prespecified subgroup analysis with pre-registered statistical plan
Weaknesses
- CAC score was not randomized; it is an observational baseline variable
- Blinding was unknown, potentially introducing detection bias in outcome assessment
- Follow-up duration (median 3.5 years) is insufficient to assess long-term prognostic value
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This was a really good study because it followed lots of people from many countries, used the same tests on everyone, and checked for other things that could affect heart health. That makes us trust the results more than if it were just a few people or done in one clinic.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
81 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1749)+20/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 573 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design cannot establish causation — the findings describe an association, not a cause. Although this is a randomized trial, the randomization was applied to the choice of diagnostic test (CT vs ICA), not to CAC score levels. CAC score is an observed baseline characteristic, not a randomized intervention. Therefore, the association between CAC score and MACE is observational within the randomized trial and cannot establish causation.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study appears independently conducted with no evidence of industry control over design, analysis, or publication.
Funders
Independent Analysis Safeguards
- Prespecified subgroup analysis within a multicenter randomized trial
- Ethical review by multiple national and local ethics committees
- Statistical analysis plan pre-registered (DISCHARGE SAP)
- Data analyzed by experienced radiologists using standardized Agatston method
The study is part of the DISCHARGE trial, which received funding from multiple public and non-industry sources across 16 European countries. No industry funding or author affiliations with commercial entities are disclosed. The methodology is transparent, with pre-registered analysis plans and standardized imaging protocols, reducing risk of bias.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
82 researchersIf this is your work, this is how we attribute it on Fit Body Science. Federico Biavati is listed as the lead author.
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 3 claims
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 2 claims
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 3 claims